Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
Jama OncologyPeer ReviewedCharles S. Fuchs +282018Journals
clinicaltrials.gov Identifier: NCT02335411.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support